Ruptured cerebral arteriovenous malformations: Outcomes analysis after microsurgery

Rabih Aboukaïs1, Paulo Marinho1, Marc Baroncini1

  • 1Department of Neurosurgery, Lille University Hospital, France.

Abstract

Insights

Microsurgical treatment for ruptured arteriovenous malformations (rAVM) yielded good functional outcomes in 83% of patients. Careful consideration of residual rAVM is crucial to prevent rebleeding.

Area of Science:

  • Neurosurgery
  • Vascular Neurology
  • Radiology

Background:

  • Recurrent arteriovenous malformations (rAVM) pose significant challenges in neurosurgical practice.
  • Evaluating functional outcomes and residual risks post-treatment is essential for patient management.

Purpose of the Study:

  • To assess the functional results and postoperative remnant rates in patients treated for rAVM via microsurgery.
  • To identify predictors of favorable outcomes and residual malformations.

Main Methods:

  • Retrospective analysis of 139 patients with rAVM treated between 2002 and 2012.
  • Preoperative assessment included age, World Federation of Neurosurgical Societies (WFNS) score, and Stereotactic পরিসংখ্যান (SPM) grade.
  • Postoperative evaluation at 3 months used the modified Rankin Scale (mRS), with conventional angiography at 2 weeks and 1 year.

Main Results:

  • 83% of patients achieved a good functional outcome (mRS ≤2).
  • Complete obliteration was achieved in 89.5% after initial microsurgery.
  • A remnant rAVM was detected in 10.5% on early angiography, with recurrence in 4.5% (all <18 years old).
  • Predictors of good outcome included younger age, lower WFNS and SPM grades, and absence of hydrocephalus.
  • Predictors of remnant rAVM included higher WFNS and SPM grades and limited preoperative imaging.

Conclusions:

  • Microsurgery offers good functional outcomes for the majority of rAVM patients.
  • Even patients with poor initial neurological status can benefit from surgical intervention.
  • Multidisciplinary discussion is vital for managing residual rAVM to mitigate rebleeding risk.

Related Concept Videos